Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 450

1.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
2.

Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.

Kasper S, Tauscher J, Küfferle B, Barnas C, Pezawas L, Quiner S.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 4:83-9. Review.

PMID:
10654113
3.

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder.

Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB.

Am J Psychiatry. 1995 Sep;152(9):1359-61.

PMID:
7653693
4.

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.

J Nucl Med. 2000 Jan;41(1):36-44.

5.

[123I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa.

Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A, Asenbaum S, Lennkh C, Praschak-Rieder N, Brücke T, Kasper S.

Biol Psychiatry. 2001 Feb 15;49(4):326-32.

PMID:
11239903
6.

Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, Maciejewski PK, O'Malley S, Innis RB.

Synapse. 2001 Sep 15;41(4):275-84.

PMID:
11494398
7.

Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents.

Dahlström M, Ahonen A, Ebeling H, Torniainen P, Heikkilä J, Moilanen I.

Mol Psychiatry. 2000 Sep;5(5):514-22.

PMID:
11032385
8.

Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls.

Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S.

Psychol Med. 2001 Nov;31(8):1467-73.

PMID:
11722161
9.
10.

No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.

Willeit M, Stastny J, Pirker W, Praschak-Rieder N, Neumeister A, Asenbaum S, Tauscher J, Fuchs K, Sieghart W, Hornik K, Aschauer HN, Brücke T, Kasper S.

Biol Psychiatry. 2001 Jul 1;50(1):8-12.

PMID:
11457418
11.

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study.

Stamenkovic M, Schindler SD, Asenbaum S, Neumeister A, Willeit M, Willinger U, de Zwaan M, Riederer F, Aschauer HN, Kasper S.

Eur Neuropsychopharmacol. 2001 Feb;11(1):69-74.

PMID:
11226814
12.

Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder.

Cheon KA, Ryu YH, Namkoong K, Kim CH, Kim JJ, Lee JD.

Psychiatry Res. 2004 Jan 15;130(1):85-95.

PMID:
14972371
13.

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R.

Biol Psychiatry. 2000 Mar 1;47(5):371-9.

PMID:
10704949
14.

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA.

Arch Gen Psychiatry. 2004 Dec;61(12):1271-9.

PMID:
15583118
15.

Striatal dopamine transporter density in major depression.

Laasonen-Balk T, Kuikka J, Viinamäki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J.

Psychopharmacology (Berl). 1999 Jun;144(3):282-5.

PMID:
10435396
16.

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB.

J Nucl Med. 1998 Sep;39(9):1500-8.

17.

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S.

Am J Psychiatry. 2004 May;161(5):826-35.

PMID:
15121647
18.

Reduced serotonin transporter binding in binge eating women.

Kuikka JT, Tammela L, Karhunen L, Rissanen A, Bergström KA, Naukkarinen H, Vanninen E, Karhu J, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Uusitupa M.

Psychopharmacology (Berl). 2001 May;155(3):310-4.

PMID:
11432694
19.

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL, et al.

Synapse. 1993 Apr;13(4):295-309.

PMID:
7683143
20.

Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.

Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH; SPECT study.

Am J Psychiatry. 2004 Aug;161(8):1496-8.

PMID:
15285982

Supplemental Content

Support Center